NIA Funding Line Policy for FY 2022
Update (9/1/2022): The tables below were updated to reflect pay lines for FY 2022 end of year.
NIA and NIH received an appropriation through the H.R. 2471, the “Consolidated Appropriations Act, 2022,” which provides full-year funding through September 30, 2022.
NIA will now pay FY 2022 non-competing awards at 100% of the committed level as shown in the Notice of Award. NIA plans to restore the cuts of those non-competing grants that were previously paid at 90% earlier in this fiscal year.
General Allocation
NIA is reducing FY 2022 competing awards by 18% on average. This average cut policy applies to all research project awards except R03s (small grants), R21s (exploratory/developmental awards), and R15s (Academic Research Enhancement Awards and the NIH Research Enhancement Awards program). These awards (R03, R21, R15) generally receive the study-section-recommended amount of support. The 18% cut remains an average. Individual awards may be reduced by more or less than that percentage.
Alzheimer’s Allocation
NIA is paying awards at their full study-section-recommended amounts, unless concerns about overlap or similar issues reduce the amount awarded.
Applications |
General pay line, < $500k |
General pay line, ≥ $500k |
AD/ADRD pay line |
---|---|---|---|
All (except below) |
15% |
12% |
28% |
New Investigator R01s |
18% |
15% |
31% |
Early Stage Investigator R01s |
20% |
17% |
33% |
Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may alternatively provide short-term support (R56) or invite a re-submission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on high priorities of the Institute.
Applications |
General pay line |
AD/ADRD pay line |
---|---|---|
Program projects |
20 |
40 |
Other NIA-reviewed research |
20 |
40 |
Parent career development awards |
21 |
35 |
Parent fellowship awards |
30 |
40 |
Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may invite a re-submission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on high priorities of the Institute.
All other categories of awards (Conference, Institutional Training, Small Business) are allocation-based rather than based on a funding line.